Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

87
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
87
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

289
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
289
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

176
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
176
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

387
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
387
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

228
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
228

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MAPK signaling pathway and rhizosphere modulation: mechanisms of arbuscular mycorrhizal symbiosis in enhancing Phragmites communis tolerance to triclocarban stress.

Mycorrhiza·2026
Same author

Aqueous PFOS exposure decouples gaseous carbon loss from mineral-associated carbon retention in controlled wetland-interface mesocosms.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Giant surface potentials in organic films enable electrode-free self-driven water droplets.

Materials horizons·2026
Same author

Discussion on ''Nonparanormal Adjusted Marginal Inference'' by Susanne Dandl and Torsten Hothorn.

Biometrics·2026
Same author

A digital twin methodology using retrospective patient data for sample size reduction in Alzheimer's disease clinical trials.

Alzheimer's research & therapy·2026
Same author

It's about time: The association between abacavir and cardiovascular disease.

Antiviral therapy·2026

Related Experiment Video

Updated: Sep 14, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

706

Sparse 2-stage Bayesian meta-analysis for individualized treatments.

Junwei Shen1, Erica E M Moodie1, Shirin Golchi1

  • 1Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec H3A 1G1, Canada.

Biometrics
|July 24, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a Bayesian meta-analysis for individualized treatment rules using multisite data without sharing patient-level information. The method effectively identifies optimal treatment strategies, demonstrated by Warfarin dosing.

Keywords:
Bayesian meta-analysisindividualized treatment rulesmultisite studiespersonalized medicine

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.5K

Related Experiment Videos

Last Updated: Sep 14, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

706
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.5K

Area of Science:

  • Biostatistics
  • Pharmacogenetics
  • Clinical Trial Design

Background:

  • Individualized treatment rules (ITRs) optimize patient care by tailoring treatments based on characteristics.
  • Estimating ITRs requires detecting treatment effect variability, often needing large, multisite datasets.
  • Multisite data analysis faces challenges like data sharing constraints and statistical sparsity.

Purpose of the Study:

  • To develop a robust method for estimating ITRs using multisite data while preserving data privacy.
  • To address data sparsity and small treatment-covariate interactions common in multisite studies.
  • To optimize patient outcomes through data-driven, personalized treatment strategies.

Main Methods:

  • A two-stage Bayesian meta-analysis approach was employed.
  • The method estimates ITRs using multisite data without disclosing individual-level data.
  • The approach is designed to handle data sparsity and identify treatment effect variability.

Main Results:

  • Simulation studies confirmed the approach provides consistent estimates for optimal ITR parameters.
  • The method successfully estimated an optimal Warfarin dose strategy using real-world pharmacogenetics data.
  • The Bayesian meta-analysis effectively managed challenges of data sparsity and small interaction effects.

Conclusions:

  • The proposed Bayesian meta-analysis is a powerful tool for estimating ITRs from multisite data.
  • This approach facilitates personalized medicine by optimizing treatment strategies without compromising data privacy.
  • The method offers a viable solution for complex pharmacogenetic studies with sparse data.